These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 9675657)

  • 21. Effect of glutathione depletion and oral N-acetyl-cysteine treatment on CD4+ and CD8+ cells.
    Kinscherf R; Fischbach T; Mihm S; Roth S; Hohenhaus-Sievert E; Weiss C; Edler L; Bärtsch P; Dröge W
    FASEB J; 1994 Apr; 8(6):448-51. PubMed ID: 7909525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyl cysteine enhances the response to interferon-alpha in chronic hepatitis C: a pilot study.
    Beloqui O; Prieto J; Suárez M; Gil B; Qian CH; García N; Civeira MP
    J Interferon Res; 1993 Aug; 13(4):279-82. PubMed ID: 8228388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Absence of antiviral activity of high-dose subcutaneous beta-interferon in patients with chronic infection by genotype 1 virus C hepatitis].
    Jiménez Sáenz M; Carmona Soria I; Caunedo Alvarez A; González Vílchez J
    Med Clin (Barc); 2000 May; 114(18):717. PubMed ID: 10916795
    [No Abstract]   [Full Text] [Related]  

  • 24. Stanford NAC study: glutathione level predicts survival.
    James JS
    AIDS Treat News; 1997 Mar; (No 266):1-5. PubMed ID: 11364246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurosarcoidosis associated with interferon therapy.
    Miwa H; Furuya T; Tanaka S; Mizuno Y
    Eur Neurol; 2001; 45(4):288-9. PubMed ID: 11385273
    [No Abstract]   [Full Text] [Related]  

  • 26. Cysteine and glutathione concentrations in plasma and bronchoalveolar lavage fluid after treatment with N-acetylcysteine.
    Bridgeman MM; Marsden M; MacNee W; Flenley DC; Ryle AP
    Thorax; 1991 Jan; 46(1):39-42. PubMed ID: 1871695
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acute severe exacerbation of chronic hepatitis B with cyclosporin A and interferon-beta: a case report.
    Ishiwata N; Noguchi O; Koyama N; Sakamoto H; Hirata R; Enomoto N; Tanaka Y; Marumo F; Sato C
    Am J Gastroenterol; 1995 May; 90(5):853-4. PubMed ID: 7733115
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prolonged use of N-acetyl-cysteine by oral route].
    Saraiva PA; Giovani L; Giordan EA; Leitão FB
    Rev Hosp Clin Fac Med Sao Paulo; 1980 Apr; 35(2):56-9. PubMed ID: 7414175
    [No Abstract]   [Full Text] [Related]  

  • 29. [Local effect of the combination thiamphenicol N-acetyl-L-cysteine in acute and chronic purulent maxillary sinusitis].
    Albernaz PL; Lanzellotti WP; Ganança MM; Fischer AR
    Hospital (Rio J); 1969 Oct; 76(4):1411-7. PubMed ID: 5308120
    [No Abstract]   [Full Text] [Related]  

  • 30. [A new substance, N-acetyl-L-cysteine, in the treatment of tracheotomized patients].
    Lungarotti R; Pauli P
    Clin Ter; 1965 Dec; 35(5):429-37. PubMed ID: 5888429
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effect of N-acetyl-L-cysteine injection as a premedication for bronchography].
    Ishikawa S; Masuda S; Ono M; Seimiya H; Itaya H
    Kyobu Geka; 1966 Jan; 19(1):47-54. PubMed ID: 6010451
    [No Abstract]   [Full Text] [Related]  

  • 32. Cysteine and glutathione in catabolic conditions and immunological dysfunction.
    Dröge W
    Curr Opin Clin Nutr Metab Care; 1999 May; 2(3):227-33. PubMed ID: 10456252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fluidizing action of N-acetyl-L-cysteine in the lytic therapy of renal calculosis].
    Dormia E
    Arch Ital Urol Nefrol; 1967 Sep; 39(5):404-10. PubMed ID: 5608184
    [No Abstract]   [Full Text] [Related]  

  • 34. [N-Acetyl-L-cysteine in 20 percent solution in prophylaxis of anesthesiologic complications].
    Lungarotti R
    Clin Ter; 1966 Mar; 36(6):526-38. PubMed ID: 5944511
    [No Abstract]   [Full Text] [Related]  

  • 35. Erratum to: Neuronal Glutathione Content and Antioxidant Capacity can be Normalized In Situ by N-acetyl Cysteine Concentrations Attained in Human Cerebrospinal Fluid.
    Reyes RC; Cittolin-Santos GF; Kim JE; Won SJ; Brennan-Minnella AM; Katz M; Glass GA; Swanson RA
    Neurotherapeutics; 2016 Jan; 13(1):239. PubMed ID: 26659493
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of N-acetyl-cysteine on lymphomonocyte glutathione and response to interferon treatment in C-virus chronic hepatitis.
    Cimino L; Belisario MA; Intrieri M; D'Ascoli B; Sacchetti L; Salvatore F; Budillon G
    Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):189-93. PubMed ID: 9675657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S; Kawase I; Nakamura H
    Hepatogastroenterology; 2003; 50(54):2112-6. PubMed ID: 14696476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The combination therapy of interferon and amantadine hydrochloride for patients with chronic hepatitis C.
    Nakamura H; Uyama H; Enomoto H; Kishima Y; Yamamoto M; Yoshida K; Okuda Y; Hirotani T; Kuroda T; Ito H; Matsuda M; Terabayashi M; Noguchi S
    Hepatogastroenterology; 2003; 50(49):222-6. PubMed ID: 12630027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Twice-a-day versus once-a-day interferon-beta therapy in chronic hepatitis C.
    Kaito M; Yasui-Kawamura N; Iwasa M; Kobayashi Y; Nakagawa N; Fujita N; Ikoma J; Gabazza EC; Watanabe S; Adachi Y
    Hepatogastroenterology; 2003; 50(51):775-8. PubMed ID: 12828083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of chronic hepatitis B with high-dose intravenous N-acetyl-L-cysteine.
    Weidenbach H; Orth M; Adler G; Mertens T; Schmid RM
    Hepatogastroenterology; 2003; 50(54):2105-8. PubMed ID: 14696474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.